Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Tim Brighton"'
Autor:
Helen Crowther, Huyen Tran, Paul Ockelford, Vivien M Chen, Beng H. Chong, Eileen Merriman, Simon McRae, Tim Brighton, Jennifer Curnow, Gordon Royle, Sanjeev Chunilal, Mark Smith, Huy Tran, Alison Slocombe
Publikováno v:
Thrombosis research. 207
Background Treatment of low-risk patients with isolated symptomatic distal deep vein thrombi (IDDVT) is uncertain. Objective: assess whether two weeks of therapeutic anticoagulation is efficacious/safe for IDDVT. Primary outcome: symptomatic three-mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c82afe3fd9adef428555293a4dd7458
https://pubmed.ncbi.nlm.nih.gov/34530387
https://pubmed.ncbi.nlm.nih.gov/34530387
Autor:
Harry Iland, Ken Bradstock, John Seymour, Mark Hertzberg, Andrew Grigg, Kerry Taylor, John Catalano, Paul Cannell, Noemi Horvath, Sandra Deveridge, Peter Browett, Tim Brighton, Li Chong, Francisca Springall, Juliet Ayling, Alberto Catalano, Shane Supple, Marnie Collins, Juliana Di Iulio, John Reynolds
Publikováno v:
Haematologica, Vol 97, Iss 2 (2012)
Background Initial therapy for patients with acute promyelocytic leukemia most often involves the combination of all-trans-retinoic acid with anthracycline-based chemotherapy. The role of non-anthracycline drugs in induction and consolidation is less
Externí odkaz:
https://doaj.org/article/740f6d736e0d4fe0ace5749b6c255562
Autor:
Stephen B. Ting, Vivien M Chen, Tim Brighton, Jocelyn Tan, Jay Hocking, James Nguyen, Huyen Tran, Sanjeev Chunilal
Publikováno v:
The Medical Journal of Australia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ae6dc8f6eb00d9f0eef6b29e610c6f
https://doi.org/10.5694/mja2.51135
https://doi.org/10.5694/mja2.51135
Autor:
Susan Jarvis, Tim Brighton, David J. Rabbolini, Joanne Joseph, Qin Liu, Marie-Christine Morel-Kopp, Dea Donikian, Kenny Tang
Publikováno v:
Pathology. 50:S108-S109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fea99a1c192d77ada9d417d3339b84c
https://doi.org/10.1016/j.pathol.2017.12.306
https://doi.org/10.1016/j.pathol.2017.12.306
Autor:
Juliana Di Iulio, Harry J. Iland, John F. Seymour, Shane G. Supple, Sandra Deveridge, Marnie Collins, Peter Browett, John Catalano, John V. Reynolds, Mark Hertzberg, Noemi Horvath, Li Chong, Juliet Ayling, Tim Brighton, Kenneth F. Bradstock, Alberto Catalano, Kerry Taylor, Francisca Springall, Paul Cannell, Andrew Grigg
Publikováno v:
Haematologica. 97:227-234
Background Initial therapy for patients with acute promyelocytic leukemia most often involves the combination of all- trans -retinoic acid with anthracycline-based chemotherapy. The role of non-anthracycline drugs in induction and consolidation is le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e498696fcc8e14aac82d7de6d1a378
https://doi.org/10.3324/haematol.2011.047506
https://doi.org/10.3324/haematol.2011.047506
Autor:
Tim Brighton, Sanjeev Chunilal, Simon McRae, Laura Young, Claire McLintock, Nolan Mcdonnell, Barry N J Walters, Huyen Tran, Gustaaf A. Dekker, Peter Muller
Publikováno v:
Australian and New Zealand Journal of Obstetrics and Gynaecology. 52:14-22
Venous thromboembolism (VTE) in pregnancy and the postpartum is an important cause of maternal morbidity and mortality; yet, there are few robust data from clinical trials to inform an approach to diagnosis and management. Failure to investigate symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71d9ec26ce92506ff516f3a98b90cfbb
https://doi.org/10.1111/j.1479-828x.2011.01361.x
https://doi.org/10.1111/j.1479-828x.2011.01361.x
Autor:
Nolan Mcdonnell, Tim Brighton, Simon McRae, Sanjeev Chunilal, Gus A. Dekker, Laura Young, Barry N J Walters, Huyen Tran, Peter Muller, Claire McLintock
Publikováno v:
Australian and New Zealand Journal of Obstetrics and Gynaecology. 52:3-13
Pregnancy is a risk factor for venous thromboembolism (VTE), an important cause of maternal morbidity and mortality. Although there is a 4–5-fold increased risk compared to that of nonpregnant women of the same age, the absolute risk is low at no m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4166531294e9b504d77b46681af18a42
https://doi.org/10.1111/j.1479-828x.2011.01357.x
https://doi.org/10.1111/j.1479-828x.2011.01357.x
Autor:
Yonghua Sheng, Stephen W. Reddel, Herbert Herzog, Ying Xia Wang, Tim Brighton, Malcolm P. France, Sarah A. Robertson, Steven A. Krilis
Publikováno v:
Europe PubMed Central
Autoimmune antibodies to beta(2)-glycoprotein I (beta2GPI) have been proposed to be clinically relevant because of their strong association with thrombosis, miscarriage, and thrombocytopenia. By using a homologous recombination approach, beta2GPI-nul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c93272606316952429ee614ed41755c4
https://doi.org/10.1074/jbc.m010990200
https://doi.org/10.1074/jbc.m010990200
Publikováno v:
Journal of Paediatrics and Child Health. 43:848-850
The commonest cause of isolated thrombocytopenia in an otherwise well child is idiopathic thrombocytopenic purpura (ITP). The inherited thrombocytopenias such as Bernard-Soulier syndrome are rare but often misdiagnosed as ITP owing to a similar clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b63717090ba358ed9c60e0a26b5cc67
https://doi.org/10.1111/j.1440-1754.2007.01240.x
https://doi.org/10.1111/j.1440-1754.2007.01240.x
Autor:
Tim Brighton, Shiying Silvia Zheng
Publikováno v:
Pathology. 48:S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33cf76584d5e3ae038550aa79eeaa766
https://doi.org/10.1016/j.pathol.2015.12.088
https://doi.org/10.1016/j.pathol.2015.12.088